Trading Picks: $SYN second Phase 2 clinical trial met its primary endpoint #AHtrading @ $1.80 UP 19%

Wednesday, January 20, 2016

$SYN second Phase 2 clinical trial met its primary endpoint #AHtrading @ $1.80 UP 19%

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)